NORWALK, Conn., Jan. 16, 2015 /PRNewswire/ -- UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, provides special coverage on advances in migraine and headache research.
Migraine affects more than 10% of persons worldwide and about 12% of Americans, including 3 times as many women as men. Fewer than half of patients are thought to have received a proper diagnosis, and there is no cure because the pathophysiology is not fully understood. Better understanding of the causes and related issues could result in enhanced patient care and prevention.
Recent developments in migraine and headache management covered on Neurology Times include the following:
- sTMS: Promising Migraine Therapy: Transcranial magnetic stimulation is a promising, effective, well-tolerated and safe treatment option for migraine with and without aura, episodic or chronic.
- Headache Imaging Can Spot Brain Tumors: Many patients with brain tumors present with isolated headaches but no other symptoms. Should neuroimaging be used to help the diagnosis? Researchers address the pros and cons.
- Migraine May Double Bell Palsy Risk: This is a newly identified association between the conditions, and they may share a common underlying link. More research could lead to better treatments.
- 5 Headache Headlines from 2014: Medication-overuse headache, chronic migraine, obesity and headache, migraine in children, thunderclap headache—these review articles published in 2014 cover a variety of critical issues.
About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Connect brings together UBM's healthcare business, UBM Medica US; UBM Canon's advanced design and manufacturing event, online and print brands; UBM Connect New York's catering, cruise shipping, customer management, and fine, specialty and custom chemical communities; and UBM Mexico's concrete show. For more information, visit www.UBMMedicaUS.com.
About UBM plc
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.
For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.
Jason J. Golden
Content Marketing Manager
SOURCE UBM Medica US